Skip to main content
. Author manuscript; available in PMC: 2020 Jan 28.
Published in final edited form as: Curr Diab Rep. 2019 Jun 27;19(8):48. doi: 10.1007/s11892-019-1176-8

Table 1.

List of somatic cell types as a potential source for generating new β-cells

Cell type Treatment/modification Species Reference
Hepatocytes Overexpression of Pdx1, NeuroD1, Ngn-3, MafA/B Mouse [2226]
Adult and fetal hepatocytes Overexpression of PDX-1 Human [2729]
Enterocytes Overexpression of Pdx1, Ngn-3, MafA - GLP1 treatment Mouse [30,31]
Enteroendocrine progenitors Downregulation of FoxO1 Mouse [32]
Enterocytes Downregulation of FOXO1 - GLP1 treatment Human [31, 33]
Acinar cells Overexpression of Pdx1, Ngn-3, MafA - treatment with cytokines, EGF or CNTF Mouse [3437]
Treatment with BMP-7 Human [38]
Ductal cells Transduction of Pdx1 Rat [39]
Treatment with cytokines Mouse/human [40]
α-cells Overexpression of Pax4 - downregulation of Arx and Dnmt1 - treatment with alloxan, PDL, or acinar damage Mouse [4146]
Treatment with GABA, artemisinins Mouse/human [47, 48•]
Overexpression of PDX-1 and MAFA Human [49, 50]